Achieve Life Sciences, Inc.
ACHV
$4.62
-$0.16-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.44M | -12.72M | -12.83M | -12.36M | -12.51M |
| Total Depreciation and Amortization | 54.00K | 55.00K | 62.00K | 58.00K | 57.00K |
| Total Amortization of Deferred Charges | 41.00K | -14.00K | 14.00K | 14.00K | 9.00K |
| Total Other Non-Cash Items | 2.42M | 3.01M | 2.32M | 1.69M | 1.90M |
| Change in Net Operating Assets | 597.00K | 595.00K | -660.00K | 1.41M | 171.00K |
| Cash from Operations | -11.33M | -9.07M | -11.09M | -9.19M | -10.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.65M | 6.70M | 11.35M | 11.72M | 13.27M |
| Cash from Investing | -12.65M | 6.70M | 11.35M | 11.72M | 13.27M |
| Total Debt Issued | -- | -- | -- | 0.00 | 9.81M |
| Total Debt Repaid | -- | -- | -- | 0.00 | -18.11M |
| Issuance of Common Stock | 4.04M | 41.22M | -- | 682.00K | 183.00K |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.04M | 41.22M | -- | 682.00K | -8.11M |
| Foreign Exchange rate Adjustments | -1.00K | 2.00K | -2.00K | -1.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.94M | 38.86M | 263.00K | 3.21M | -5.21M |